BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11423580)

  • 1. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.
    Zoccali C; Mallamaci F; Benedetto FA; Tripepi G; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Cottini E; Malatino LS
    J Am Soc Nephrol; 2001 Jul; 12(7):1508-1515. PubMed ID: 11423580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
    Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
    Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
    Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
    Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass.
    Chello M; Mastroroberto P; Perticone F; Cirillo F; Bevacqua E; Olivito S; Covino E
    Eur J Cardiothorac Surg; 2001 Jul; 20(1):140-6. PubMed ID: 11423287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
    Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
    Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
    Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
    Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease.
    Tripepi G; Mattace-Raso F; Mallamaci F; Benedetto FA; Witteman J; Malatino L; Zoccali C
    Hypertension; 2009 Oct; 54(4):818-24. PubMed ID: 19635983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C; Metzele A; Kochs M; Hombach V; Grünert A
    Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of brain natriuretic peptides in hemodialysis patients.
    Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
    Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients.
    Yoshihara F; Horio T; Nakamura S; Yoshii M; Ogata C; Nakahama H; Inenaga T; Kangawa K; Kawano Y
    Kidney Int; 2005 Sep; 68(3):1355-63. PubMed ID: 16105071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.